169 related articles for article (PubMed ID: 15704804)
21. [Acute episode].
Schölmerich J;
Z Gastroenterol; 2003 Jan; 41(1):27-30. PubMed ID: 12541170
[No Abstract] [Full Text] [Related]
22. Correction of mesalazine-induced neutropenia with high-dose G-CSF.
Bhidayasiri R; Katz JA; Sokos DR
Am J Gastroenterol; 2000 Nov; 95(11):3321-2. PubMed ID: 11095375
[No Abstract] [Full Text] [Related]
23. Drug insight: aminosalicylates for the treatment of IBD.
Nielsen OH; Munck LK
Nat Clin Pract Gastroenterol Hepatol; 2007 Mar; 4(3):160-70. PubMed ID: 17339853
[TBL] [Abstract][Full Text] [Related]
24. Mesalazine-induced aplastic anemia.
Wiesen A; Wiesen J; Limaye S; Kaushik N
Am J Gastroenterol; 2009 Apr; 104(4):1063. PubMed ID: 19259075
[No Abstract] [Full Text] [Related]
25. Mesalamine for refractory celiac disease: an old medicine for a new disease.
Green PH; Lebwohl B
J Clin Gastroenterol; 2011 Jan; 45(1):1-3. PubMed ID: 21063211
[No Abstract] [Full Text] [Related]
26. Mesalazine-induced lupus.
Timsit MA; Anglicheau D; Lioté F; Marteau P; Dryll A
Rev Rhum Engl Ed; 1997 Oct; 64(10):586-8. PubMed ID: 9385697
[TBL] [Abstract][Full Text] [Related]
27. The suspension of an announced trial on relapse prevention in Crohn's ileitis with a 5-ASA formulation in microgranular form.
Prantera C; Bellinvia S
Dig Liver Dis; 2005 Feb; 37(2):135-6. PubMed ID: 15733528
[No Abstract] [Full Text] [Related]
28. [Paradigmatic shift in drug treatment of Crohn disease].
Munck LK
Ugeskr Laeger; 2005 Aug; 167(33):3013. PubMed ID: 16109239
[No Abstract] [Full Text] [Related]
29. Presentation of Crohn's disease as metastatic cutaneous non-caseating granulomatous lesions.
Delgado J; Delgado B; Sztarkier I; Cagnano E; Sperber AD; Fich A
Isr Med Assoc J; 2003 Dec; 5(12):897-8. PubMed ID: 14689766
[No Abstract] [Full Text] [Related]
30. [A study of 5-ASA use among young patients with Crohn disease. Regular drug revision is of significance for all children with chronic disease].
Hedin A; Ehrsson H; Eksborg S; Finkel Y; Hildebrand H; Lidehäll AK
Lakartidningen; 2001 Oct; 98(40):4343-6. PubMed ID: 11685756
[No Abstract] [Full Text] [Related]
31. Probiotics (Br J Surg 2001; 88: 161-2).
Guslandi M
Br J Surg; 2001 Jun; 88(6):890-1. PubMed ID: 11412272
[No Abstract] [Full Text] [Related]
32. [5-aminosalicylic acid for induction of remission or clinical response in Crohn's disease--a survey of a Cochrane review].
Bjerrum JT; Munck LK; Nielsen OH
Ugeskr Laeger; 2011 Aug; 173(35):2110-3. PubMed ID: 21884660
[TBL] [Abstract][Full Text] [Related]
33. [Therapy of Lesniowski-Crohn disease of the upper part of the gastrointestinal tract].
Gadowska-Cicha A; Latos W; Niepsuj KJ; Sieroń A
Wiad Lek; 2005; 58(5-6):307-12. PubMed ID: 16238123
[TBL] [Abstract][Full Text] [Related]
34. Mesalazine as a maintenance treatment in Crohn's disease.
Sutherland LR; Steinhart AH
Gut; 1998 Jan; 42(1):143-4. PubMed ID: 9505902
[No Abstract] [Full Text] [Related]
35. Little benefit from mesalazine taken prophylactically after surgery for Crohn's disease.
Rutgeerts P
Gut; 2001 Apr; 48(4):452-3. PubMed ID: 11247886
[No Abstract] [Full Text] [Related]
36. Mea culpa.
Hanauer SB
Nat Clin Pract Gastroenterol Hepatol; 2008 Aug; 5(8):409. PubMed ID: 18670441
[No Abstract] [Full Text] [Related]
37. [Ulcerous colitis and Crohn's disease in members of one family: case description and review of literature].
Neĭman KP; Rumiantsev VG
Eksp Klin Gastroenterol; 2006; (3):56-60. PubMed ID: 17203844
[No Abstract] [Full Text] [Related]
38. [For treatment decision the age to be taken into account. In Crohn's disease and ulcerative colitis attention to be paid to the age at manifestation].
MMW Fortschr Med; 2009 May; 151(19):38-9. PubMed ID: 19827443
[No Abstract] [Full Text] [Related]
39. Case report: combination therapy with granulocyte apheresis and infliximab for refractory Crohn's disease.
González Carro P; Pérez Roldán F; Roncero García Escribano O; Lafuente R; Legaz Huidobro ML; Amigo Echenagusía A
J Clin Apher; 2006 Dec; 21(4):249-51. PubMed ID: 16607627
[No Abstract] [Full Text] [Related]
40. Combination therapy with symbiotics and local anti-inflammatories for red anusitis.
Cafaro D; Onofrio L; D'Agostino G
Minerva Gastroenterol Dietol; 2007 Jun; 53(2):117-23. PubMed ID: 17557039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
